Trevi Therapeutics (TRVI) News Today → Gold Mania (From Stansberry Research) (Ad) Free TRVI Stock Alerts $2.73 -0.19 (-6.51%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTrevi Therapeutics (NASDAQ:TRVI) Receives Buy Rating from Needham & Company LLCamericanbankingnews.com - May 12 at 3:57 AMBrokers Issue Forecasts for Trevi Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:TRVI)americanbankingnews.com - May 12 at 2:54 AMTrevi Therapeutics, Inc.: Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updatesfinanznachrichten.de - May 12 at 2:06 AMLeerink Partnrs Comments on Trevi Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:TRVI)americanbankingnews.com - May 11 at 4:36 AMFY2024 EPS Estimates for Trevi Therapeutics, Inc. (NASDAQ:TRVI) Cut by Leerink Partnrsmarketbeat.com - May 10 at 8:50 AMTrevi Therapeutics to Participate in Upcoming Conferencesprnewswire.com - May 9 at 7:30 AMAnalysts Are Bullish on These Healthcare Stocks: Trevi Therapeutics (TRVI), Neurogene (NGNE)markets.businessinsider.com - May 8 at 11:14 AMQ1 2024 Trevi Therapeutics Inc Earnings Callfinance.yahoo.com - May 8 at 11:14 AMTrevi Therapeutics (NASDAQ:TRVI) Rating Reiterated by Needham & Company LLCmarketbeat.com - May 8 at 10:13 AMTRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024investorplace.com - May 7 at 10:05 PMTrevi Therapeutics Reports Q1 2024 Financial Results: A Detailed Analysisfinance.yahoo.com - May 7 at 7:50 PMTrevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updatesprnewswire.com - May 7 at 4:05 PMTrevi Therapeutics (TRVI) Set to Release Earnings on Tuesdayamericanbankingnews.com - May 5 at 6:58 AMTrevi Therapeutics (TRVI) Scheduled to Post Quarterly Earnings on Tuesdaymarketbeat.com - May 2 at 9:59 AMGloria Trevi Clears First Hurdle for Lawsuit Claiming She Was Main Victim of Sex Abuseyahoo.com - May 1 at 8:55 PMTrevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024prnewswire.com - May 1 at 4:05 PMTrevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conferencefinance.yahoo.com - April 9 at 9:54 AMTrevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conferenceprnewswire.com - April 9 at 7:30 AMTrevi Therapeutics appoints new VP for clinical developmentuk.investing.com - April 4 at 7:56 PMTrevi Therapeutics to Participate in Upcoming April Eventsprnewswire.com - April 4 at 7:30 AMTrevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Teamfinance.yahoo.com - April 2 at 10:35 AMTourists throw over €1 million into Italy’s Trevi Fountain each year. Here’s what happens to itmsn.com - March 29 at 7:12 PMTrevi Italian Restaurant at Forum Shops unexpectedly closesmsn.com - March 28 at 9:44 PMProminent Trevi Italian Restaurant Abruptly Closes at the Forum Shopsmsn.com - March 27 at 1:26 PMTrevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 21 at 11:14 AMOppenheimer Reaffirms "Outperform" Rating for Trevi Therapeutics (NASDAQ:TRVI)marketbeat.com - March 21 at 9:38 AMTrevi Therapeutics, Inc.: Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - March 21 at 7:22 AMTrevi Therapeutics: Q4 Earnings Insightsbenzinga.com - March 20 at 9:21 PMTRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023msn.com - March 20 at 9:21 PMTrevi Therapeutics Inc (TRVI) Announces Year-End Financials and Progress in Clinical Trialsfinance.yahoo.com - March 20 at 9:21 PMGloria Trevi Lights Up New York, Debuts ‘Zorra' Remix With Nebulossamsn.com - March 17 at 10:44 PMGloria Trevi Lights Up New York, Debuts ‘Zorra’ Remix With Nebulossamsn.com - March 16 at 4:38 PMTrevi Therapeutics (TRVI) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 14 at 3:33 PMTrevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024finance.yahoo.com - March 13 at 8:28 PMOne million Euro gets thrown into Rome’s Trevi Fountain each year. What happens next?msn.com - March 7 at 10:39 AMprivate equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last weekfinance.yahoo.com - February 29 at 10:35 AMTrevi Therapeutics to Participate in Upcoming March Eventsfinance.yahoo.com - February 28 at 7:37 AMTrevi Therapeutics to Participate in Upcoming March Eventsprnewswire.com - February 28 at 7:30 AMTrevi Therapeutics Inc.thestreet.com - February 24 at 9:36 AMTRVI Mar 2024 2.000 callfinance.yahoo.com - February 22 at 11:20 PMTRVI Mar 2024 3.000 callfinance.yahoo.com - February 18 at 1:33 PMLeerink Partnrs Analysts Reduce Earnings Estimates for Trevi Therapeutics, Inc. (NASDAQ:TRVI)marketbeat.com - February 8 at 8:13 AMTrevi Therapeutics, Inc. (NASDAQ:TRVI) to Post Q1 2024 Earnings of ($0.09) Per Share, Leerink Partnrs Forecastsmarketbeat.com - February 7 at 8:05 AMTrevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 10:10 AMTrevi Therapeutics Inc (TRVI)investing.com - January 30 at 3:39 PMMexican popstar Gloria Trevi reflects on career, prison time, new tour: 'It wasn't easy'msn.com - January 22 at 10:45 AMWe're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Ratefinance.yahoo.com - January 19 at 2:05 PMTrevi Therapeutics, Inc. (TRVI) Upgraded to Strong Buy: Here's Whyfinance.yahoo.com - January 17 at 2:37 PMTrevi Therapeutics, Inc.: Trevi Therapeutics Provides Business Updatesfinanznachrichten.de - January 4 at 1:29 PMTrevi Therapeutics Provides Business Updatesfinance.yahoo.com - January 4 at 8:29 AM Get Trevi Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide TRVI Media Mentions By Week TRVI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRVI News Sentiment▼-0.130.58▲Average Medical News Sentiment TRVI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRVI Articles This Week▼182▲TRVI Articles Average Week Get Trevi Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LFCR News GALT News ACRV News RIGL News OMER News GBIO News OVID News ATOS News RENB News MACK News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRVI) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
